Stem Cells Inhibition by Bevacizumab in Combination with Neoadjuvant Chemotherapy for Breast Cancer

Preclinical works have suggested cytotoxic chemotherapies may increase the number of cancer stem cells (CSC) whereas angiogenesis inhibition may decrease CSC proliferation. We developed a proof of concept clinical trial to explore bevacizumab activity on breast CSC. Breast cancer patients requiring...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Clin Med
Main Authors: Sabatier, Renaud, Charafe-Jauffret, Emmanuelle, Pierga, Jean-Yves, Curé, Hervé, Lambaudie, Eric, Genre, Dominique, Houvenaeghel, Gilles, Viens, Patrice, Ginestier, Christophe, Bertucci, François, Sfumato, Patrick, Extra, Jean-Marc, Gonçalves, Anthony
Formato: Artigo
Idioma:Inglês
Publicado em: MDPI 2019
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6572380/
https://ncbi.nlm.nih.gov/pubmed/31064127
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/jcm8050612
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados